Skip to content
healthcare.dev

Mylotarg

NDC 0008-4510, gemtuzumab ozogamicin, injection, powder, lyophilized, for solution, from Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc..

Product NDC
0008-4510
Status
Listed
Labeler
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761060
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0008-4510 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GEMTUZUMAB OZOGAMICIN5 mg/5mL

Pharmacologic classes

CD33-directed Antibody Interactions [MoA]; CD33-directed Immunoconjugate [EPC]

Package NDCNDC-11Package
0008-4510-01000084510011 VIAL, SINGLE-DOSE in 1 CARTON (0008-4510-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/32fd2bb2-1cfa-4250-feb8-d7956c794e05
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0008-4510

Use it

Look up 0008-4510 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0008-4510 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0008-4510. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.